- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05942482
Head and Neck Paragangliomas: A 16-year Experience of a University Hospital in Turkey
September 14, 2023 updated by: Fazıl Necdet Ardıç, Pamukkale University
The aim of the study is to examine the head and neck paraganglioma cases treated in Pamukkale University hospital between 2007-2023 and improve our understanding of these cases and contribute to the knowledge surrounding head and neck paragangliomas.
Study Overview
Status
Completed
Conditions
Detailed Description
39 patients were selected and analyzed retrospectively.
Demographic informations, complaints at the time of admission, radiological examinations, paraganglioma types, stages, postoperative complications, and relapsed cases were recorded.Preoperative staging plays a crucial role in surgical planning and predicting potential intraoperative complications.
In such cases, combination therapy alongside surgery may improve treatment outcomes.
Study Type
Observational
Enrollment (Actual)
39
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Denizli, Turkey, 20070
- Pamukkale University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients who underwent head and neck surgeries at Pamukkale University Hospital between 2007 and 2023, resulting in a histopathological diagnosis of paraganglioma
Description
Inclusion Criteria:
- Histopathological diagnosis of carotid paraganglioma
- Histopathological diagnosis of vagal paraganglioma
- Histopathological diagnosis of jugular paraganglioma
- Histopathological diagnosis of tympanic paraganglioma
Exclusion Criteria:
-Inadequate information in files
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative recurrence
Time Frame: may 2023-june 2023
|
Incidence of recurrences after the surgery
|
may 2023-june 2023
|
|
Postoperative nerve paralysis
Time Frame: may 2023-june 2023
|
Incidence of facial, vagus, hypoglossus, accesorius nerve paralysis after surgery
|
may 2023-june 2023
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Fazıl N Ardıç, MD, Pamukkale University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 30, 2023
Primary Completion (Actual)
July 5, 2023
Study Completion (Actual)
July 5, 2023
Study Registration Dates
First Submitted
June 30, 2023
First Submitted That Met QC Criteria
July 11, 2023
First Posted (Actual)
July 12, 2023
Study Record Updates
Last Update Posted (Actual)
September 15, 2023
Last Update Submitted That Met QC Criteria
September 14, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Paraganglioma
-
Assistance Publique - Hôpitaux de ParisSociety for EndocrinologyRecruitingParaganglioma of Head and NeckFrance
-
Mercy ResearchCompletedNasopharyngeal Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Salivary Gland Cancer | Paraganglioma of Head and Neck | Head and Neck Sarcoma | Chordoma of Head and Neck | Chondrosarcoma of Head and Neck | Angiofibroma of Head and NeckUnited States
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
University of California, San FranciscoActive, not recruitingHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck CarcinomaUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
Matthew SpectorAlume Biosciences, Inc.Not yet recruitingHead and Neck Cancer | Head and Neck DisorderUnited States
-
Yale UniversityRecruitingHead and Neck Cancer | Head and Neck TraumaUnited States
-
University of California, San FranciscoCompleted
-
AZ Sint-Jan AVActive, not recruiting